MariMed COO Timothy Shaw acquires 42,657 shares

The remaining RSUs under the April 15, 2026 grant are scheduled to vest in equal installments on January 15 and April 15, 2027.

Rhea-AI Filing Summary

MariMed Inc. Chief Operating Officer Timothy Shaw reported exercising 42,657 restricted stock units (RSUs) into 42,657 common shares on October 15, 2026. The issuer withheld 12,520 common shares to satisfy tax withholding obligations tied to RSU vesting, and 85,312 RSUs remained after the transaction. The report also lists 2,000,000 common shares held indirectly by the Shaw Family Trust; Shaw disclaims beneficial ownership of those shares.

Insider Trade Summary

42,657 shares exercised/converted

Exercise 4 txns

Insider Shaw Timothy

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU) F1, F4	42,657	$0.00	$0.00
Exercise	Common stock F1	42,657	$0.00	$0.00
Tax Withholding	Common stock F2	12,520	$0.06	$751.20
holding	Common stock F3	--	--	--

Holdings After Transaction: Restricted Stock Units (RSU) — 85,312 contracts (Direct); Common stock — 9,491,259 shares (Direct); Common stock — 2,000,000 shares (Indirect, By the Shaw Family Trust)

Footnotes (4)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. F3. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. F4. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in two equal installments on each of January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs exercised: 42,657 RSUs Common shares acquired: 42,657 shares Common shares withheld for tax: 12,520 shares +2 more

5 metrics

RSUs exercised 42,657 RSUs October 15, 2026

Common shares acquired 42,657 shares On conversion of RSUs on October 15, 2026

Common shares withheld for tax 12,520 shares In connection with RSU vesting on October 15, 2026

RSUs following transaction 85,312 RSUs Following the October 15, 2026 transaction

Common shares held through Shaw Family Trust 2,000,000 shares Indirect holding reported by Timothy Shaw

Key Terms

Restricted Stock Units (RSU), tax withholding obligations, irrevocable trust

3 terms

Restricted Stock Units (RSU) technical

"RSUs convert to shares of common stock on a one-for-one basis."

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with the vesting of RSUs"

irrevocable trust regulatory

"The trust is an irrevocable trust."

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MRMD shares did COO Timothy Shaw acquire and have withheld?

On October 15, 2026, Shaw converted 42,657 RSUs into 42,657 common shares, and the issuer withheld 12,520 common shares to satisfy tax withholding obligations in connection with RSU vesting.

How many RSUs remained after Timothy Shaw's MRMD transaction?

85,312 RSUs remained following the October 15, 2026 transaction.

When do Timothy Shaw's remaining MRMD RSUs vest?

The remaining RSUs from the April 15, 2026 grant are scheduled to vest in two equal installments on January 15, 2027 and April 15, 2027, under the award agreement between MariMed Inc. and Shaw.

Who holds the MRMD shares reported through the Shaw Family Trust?

The report lists 2,000,000 common shares held indirectly through the irrevocable Shaw Family Trust. Shaw's spouse is the trustee, the shares are for the benefit of Shaw's children, and Shaw disclaims beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 06:52 PM EDT Accepted by SEC EDGAR 10/15/2026 - 06:52 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shaw Timothy

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD, MASSACHUSETTS 02062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	10/15/2026		M		42,657	A	$0(1)	9,503,779	D
Common stock	10/15/2026		F		12,520(2)	D	$0.06	9,491,259	D
Common stock								2,000,000	I	By the Shaw Family Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	10/15/2026		M			42,657	(4)	(4)	Common Stock, par value $.001 per share	42,657	$0	85,312	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in two equal installments on each of January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Timothy Shaw	10/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)